These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26368820)

  • 1. Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones.
    Braun D; Schweizer U
    Endocrinology; 2015 Dec; 156(12):4720-30. PubMed ID: 26368820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Chemical Chaperone Phenylbutyrate Rescues MCT8 Mutations Associated With Milder Phenotypes in Patients With Allan-Herndon-Dudley Syndrome.
    Braun D; Schweizer U
    Endocrinology; 2017 Mar; 158(3):678-691. PubMed ID: 27977298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
    Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
    Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Phenylbutyrate Rescues Thyroid Hormone Transport in Brain Endothelial-Like Cells.
    Braun D; Bohleber S; Vatine GD; Svendsen CN; Schweizer U
    Thyroid; 2022 Jul; 32(7):860-870. PubMed ID: 35357974
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling the Biochemical Phenotype of MCT8 Mutations In Vitro: Resolving a Troubling Inconsistency.
    Braun D; Reuter U; Schweizer U
    Endocrinology; 2019 Jun; 160(6):1536-1546. PubMed ID: 31127274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorder of thyroid hormone transport into the tissues.
    Groeneweg S; Visser WE; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts.
    Groeneweg S; van den Berge A; Meima ME; Peeters RP; Visser TJ; Visser WE
    Endocrinology; 2018 Mar; 159(3):1290-1302. PubMed ID: 29309566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
    Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
    Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of Human TRIAC Transmembrane Transporters.
    Becker PC; Güth-Steffens M; Lazarow K; Sonntag N; Braun D; Masfaka I; Renko K; Schomburg L; Köhrle J; von Kries JP; Schweizer U; Krause G; Protze J
    Thyroid; 2024 Jul; 34(7):920-930. PubMed ID: 38801167
    [No Abstract]   [Full Text] [Related]  

  • 15. Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8).
    Braun D; Lelios I; Krause G; Schweizer U
    Endocrinology; 2013 Jul; 154(7):2553-61. PubMed ID: 23592749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency.
    Zung A; Sonntag N; Schweizer U; Banne E; Braun D
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2589-2601. PubMed ID: 38469646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highly Selective Fluorescent Probe for Monitoring the Thyroid Hormone Transporter Activity in Mammalian Cells.
    Giri D; Govindaraj V; Kumar S; Ungati H; Mugesh G
    Chemistry; 2024 Sep; 30(54):e202401719. PubMed ID: 38995511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Kersseboom S; Horn S; Visser WE; Chen J; Friesema EC; Vaurs-Barrière C; Peeters RP; Heuer H; Visser TJ
    Mol Endocrinol; 2014 Dec; 28(12):1961-70. PubMed ID: 25389909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 Expression.
    Wilpert NM; Krueger M; Opitz R; Sebinger D; Paisdzior S; Mages B; Schulz A; Spranger J; Wirth EK; Stachelscheid H; Mergenthaler P; Vajkoczy P; Krude H; Kühnen P; Bechmann I; Biebermann H
    Thyroid; 2020 Sep; 30(9):1366-1383. PubMed ID: 32143555
    [No Abstract]   [Full Text] [Related]  

  • 20. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis.
    Mayerl S; Müller J; Bauer R; Richert S; Kassmann CM; Darras VM; Buder K; Boelen A; Visser TJ; Heuer H
    J Clin Invest; 2014 May; 124(5):1987-99. PubMed ID: 24691440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.